Skip to main content
Clinical Trials/EUCTR2014-001299-79-DK
EUCTR2014-001299-79-DKActive, not recruitingPhase 1

Pneumococcal vaccination of rheumatoid arthritis patients in immunomodulatory therapy - Immunovax_RA

Department of Infectious Diseases, Odense University Hospital0 sitesStarted: July 7, 2014Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • - Diagnosed with rheumatoid arthritis
  • - Over 18 years old
  • - Not pregnant
  • - Receiving immunomodulatory therapy for rheumatoid arthritis (for randomized group)
  • - Patient at theumatology outpatient clinic at Odense University Hospital or King Christian X's Hospital for Rheumatic Diseases
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 2
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 98

Exclusion Criteria

  • - Hypersensitivity to diphtheria toxoid, active substance or excipients in the vaccines.
  • - Pneumovax vaccination within the last 12 months
  • - Refuses to be vaccinated

Investigators

Sponsor
Department of Infectious Diseases, Odense University Hospital

Similar Trials